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Background & aims: Seaweed including brown seaweeds with rich bioactive components may be effi-
cacious for a glycaemic management strategy and appetite control. We investigated the effects of two
brown edible seaweeds, Laminaria digitata (LD) and Undaria pinnatifida (UP), on postprandial glucose
metabolism and appetite following a starch load in a human meal study.
Methods: Twenty healthy subjects were enrolled in a randomized, 3-way, blinded cross-over trial. The
study was registered under ClinicalTrials.gov Identifier no. NCT00123456. At each test day, the subjects
received one of three meals comprising 30 g of starch with 5 g of LD or UP or an energy-adjusted control
meal containing pea protein. Fasting and postprandial blood glucose, insulin, C-peptide and glucagon-
like peptide-1 (GLP-1) concentrations were measured. Subjective appetite sensations were scored us-
ing visual analogue scales (VAS).
Results: Linear mixed model (LMM) analysis showed a lower blood glucose, insulin and C-peptide
response following the intake of LD and UP, after correction for body weight. Participants
weighing  63 kg had a reduced glucose response compared to control meal between 40 and 90 min
both following LD and UP meals. Furthermore, LMM analysis for C-peptide showed a significantly lower
response after intake of LD. Compared to the control meal, GLP-1 response was higher after the LD meal,
both before and after the body weight adjustment. The VAS scores showed a decreased appetite
sensation after intake of the seaweeds. Ad-libitum food intake was not different three hours after the
seaweed meals compared to control.
Conclusions: Concomitant ingestion of brown seaweeds may help improving postprandial glycaemic and
appetite control in healthy and normal weight adults, depending on the dose per body weight.
Clinical trial registry number: Clinicaltrials.gov (ID# NCT02608372).
© 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.M, Certified reference mate-
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for Clinical Nutrition and Metabo1. Introduction
Postprandial hyperglycaemia is characterised by a plasma
glucose level >7.8 mmol/L (140 mg/dL) 2 h after ingestion of food.
Normal fasting blood glucose levels are typically <6.1 mmol/L with
2-h postprandial plasma glucose <7.8 mmol/L (postprandial) [1].
Continued fasting and/or postprandial hyperglycaemia can lead to a
progressive decline in hepatic and peripheral insulin sensitivity,
deterioration of b-cells, and deficiencies in the incretin hormones,
glucagon-like peptide-1 (GLP-1) and glucose-dependent gastric
inhibitory peptide (GIP), secreted by the gut [2]. Restoring a normallism. All rights reserved.
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for metabolic health, as hyperglycaemia may be a predecessor for
type 2-diabetes (T2DM) development [3]. Furthermore, post-
prandial hyperglycemic events occur frequently in individuals with
T2DM, varying between 61.9 and 88.4% of the patients experiencing
hyperglycaemia once a week [4]. Therefore, minimising post-
prandial exposures to high blood glucose levels through dietary
modification is one of the potential remedies for glycaemic
management.
For centuries, seaweed has been consumed in Asian countries
like China, Malaysia and Japanwhere it is a regular part of the daily
diet. Elsewhere in the world, other seaboard countries such as
Ireland, Scotland, Wales, Iceland, Norway, Canada and Spain have
traditionally eaten seaweed but to a lesser extent [5,6]. Since
ancient times, some seaweeds have been used in Asian countries as
functional foods and medical herbs. Thus, the potential health
benefits of seaweeds for human health are of interest [7].
Consumption of whole seaweed may provide a combination of
bioactive components whichmay bemore effective than the sum of
the individual compounds in seaweed when tested individually [8].
Edible seaweeds are a particularly rich source of a variety of
resistant dietary fibers, including xylans, carrageenan, fucoidan,
laminaran and alginate. Some of these fibers are known to reduce
glycaemia and insulin levels and some of them are known to
improve satiety [9e11]. We previously showed that seaweed ex-
tracts from brown seaweeds efficiently inhibit starch-degrading
enzymes in vitro and fibers as well as polyphenols and caroten-
oids were the responsible components [12,13]. Animal models
demonstrate a positive effect on glucosemetabolism after ingestion
of some of the edible seaweed species [14,15]. However, there is a
scarcity of human studies on the short- and long-term effects of
seaweed on these endpoints. Therefore, the main aim of this study
was to investigate whether the two brown seaweeds, Laminaria
digitata (LD) and Undaria pinnatifida (UP), affect postprandial
glucose, insulin, C-peptide, and GLP-1 concentrations in healthy
adults. Moreover, we aim to evaluate the effect of these two
seaweed species on subjective appetite sensation using visual
analogue scales (VAS) and an ad libitum meal.
2. Materials and methods
2.1. Study design, ethics and protocol registration
The study had a randomized, 3-way, blinded cross-over design
consisting of three test meals given in a random order to each
participant on the different test days, which were separated by at
least 7 days for a washout period. All of the participants were
randomized by a balanced block design to one of the six possible
sequences to receive the two testmeals containing LD and UP or the
energy-adjusted control meal containing pea protein at the three
different test days, see Supplemental Fig. S1. The study was blinded
to the investigator and to the statistician. The participants were not
informed about the content of the test meal, but it was not possible
to eliminate the seaweed taste; therefore they were semi-blinded.
Participants were instructed to refrain from all kinds of seaweed
and paracetamol 48 h prior to and throughout each test day, except
for what was provided. In addition, the participants were instructed
to refrain from caffeinated beverages including coffee, black, green,
or white tea, cola, energy drinks and chocolate as well as alcohol
during this same period. Furthermore, they were instructed to
avoid intense physical activity 24 h proceeding each test day and
until the following morning.
In the evening before each test day, the participants were fasting
from 8 pm, but drinking 0.5 L of water was required between 6:00
pm and 08:00 am the next morming and again 0.5 L during the testday (08:00e12:00). For each test day, the participants had to meet,
in a 12-h fasting state at 08:00. Upon arrival, participants’ weight,
height, and waist circumference were measured. They were
instructed to lie down and rest for 10 min before the measurement
of baseline blood pressure. A venflon catheter was afterward
inserted into the antecubital vein, preferably of the right arm,
allowing repeated blood sampling throughout the day.
The recruitment was carried out between May 2015eAugust
2015 at the Department of Nutrition, Exercise, and Sports, in the
section for Preventive and Clinical Nutrition, University of Copen-
hagen, Denmark. The study protocol was approved by the munic-
ipal Ethical Committee of Copenhagen (journal no.: H 15004500) in
accordance with the Helsinki-II declaration. All participants gave
their written informed consent after having received written and
oral information about the study. The study was registered on
Clinicaltrials.gov (ID# NCT02608372). The primary outcome was
the postprandial glucose response and the secondary outcomes
were postprandial insulin response, C-peptide, GLP-1 and subjec-
tive appetite scores. The sample size was determined to obtain a
statistical power of 80% at a significance level of p < 0.05 for
38 pmol/l change.
2.2. Participants
The study participants were recruited through posters at the
University of Copenhagen and via website advertisement on http://
www.forsogsperson.dk and www.sundhed.dk. Healthy, normal
weight (BMI 20.5e25.0 kg/m2) males and females aged between 20
and 50 years old were eligible for to the study. Exclusion criteria
included, systemic infections, acute or chronic metabolic disorders,
tobacco use, breastfeeding, pregnant or planning a pregnancy, were
or had been drug addicts, iodine related intolerance or allergy,
history of surgical intervention for treatment of obesity, had been
enrolled in any human dietary or medical intervention study less
than 4 weeks before the study, or habitual alcohol consumption
above the maximal limit as recommended by the Danish Health
Authorities (14 drinks per week for males or 7 drinks per week for
females). All subjects were screened over the phone and invited to
an information meeting, if they were qualified. Upon final enroll-
ment, the subjects were randomized to one of the three test meals
and the order in which they were to consume the test meal using
the RAND function in in Microsoft Excel.
2.3. Test meals
The test meal was served in the morning at 08:45. A 150 mL
starchy drink consisting of 30 g of corn starch in water with 22 g
sugar free lemonade powder (Fun One, Stevia lemonade with
guava/lime, Kavli A/S Hvidovre, Denmark) was servedwith either of
three different meals. They consisted of 5.0 g of LA (obtained from
AlgAran Teoranta, Kilcar Co. Donegal, Ireland) or 5 g of UP (obtained
from JFC Deutschland, Dusseldorf, Germany) or 5 g of pea protein
(Pea protein Mega 83%, Natur Drogeriet, Hørning, Denmark). We
used whole seaweeds in the test meals as consumed by people in
Asia, where seaweed salads with whole or chopped leafs are
common. This provides minimal processing, thereby preserving the
seaweed constituents. The dried seaweedwere soaked in 200mL of
water for 10 min, then rinsed and drained to remove excess water.
Finally, they were cut into pieces and added with 0.5 g iodine
enriched salt (6.5 mg iodine). 0.2 g of black pepper and 4 g of fresh
lemon juice were added to the test and control meals to improve
the palatability. Together with the test meal, 500 mL of drinking
water was additionally served. The minor differences in contents of
carbohydrate, fat, and protein in the three meals were adjusted
with corn starch, rapeseed and pea protein (83%). Table 1 shows an
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test meals.
Three hours after the test meal and immediately after the last
VAS score participants were offered an ad libitum test meal to
assess their hunger. The ad libitummeal consisted of 7987.6 kJ pasta
with meat sauce, served with 250 mL water (energy: 554.5 kJ/100 g
withmacronutrient content (protein: 15.5 E %, carbohydrate: 54.5 E
% and fat: 30.1 E %). The volunteers were given 30 min to complete
this meal.2.4. Biological sampling and analysis
The subjects had for each visit, seven separate blood draws by
trained phlebotomists. Blood samples were collected at
baseline20min and then at 20, 40, 60, 90, 120 and 180min. Blood
was collected for plasma glucose analysis in 3 mL FC-mixture tubes
(VFe053SFC36, TERUMO Corporation, Tokyo, Japan) and for serum
insulin, C-peptide and GLP-1 in 4 and 6 ml additive-free tubes
(369032 and 366815 from Becton Dickinson, Plymouth, UK). Sam-
ples for plasma collection were centrifuged immediately after
sampling while serum tubes were allowed to stand at room tem-
perature for 20 min; serum and plasma were dispensed into cry-
otubes and subsequently frozen at 80 C. Samples were thawed
and assayed after they had all been collected. Plasma glucose was
determined by a standard kit on an ABX Pentra 400 analyzer
(Horiba ABX SAS, Montpellier, Cedex, France). Insulin and C-peptide
was determined by solid-phase, two-site chemiluminescent
immunometric assay, using Immulite 2000 XPi (Siemens Health-
care Diagnostic Ltd, Llaneris Gwynedd, United Kingdom). Serum
concentrations of GLP-1 were determined using an ELISA based kit
(Multi Species GLP-1 total ELISA, EZGLP1T-36K, EMD Millipore,
Burlington, USA). The kit measures both the inactive and active
form of GLP-1 (7-36- and 9-36amides) and was chosen based on
the findings by Bak et al. [16].2.5. Analyses of mineral elements
The concentration of selected mineral elements in the seaweed
samples was determined following the principles in EN15763:2009
[17]. Briefly, subsamples of seaweed (approx. 0.3 g) were digested
using 5 mL of concentrated nitric acid (SCP Science, Villebon-sur-
Yvette, France) in a microwave oven (Multiwave 3000, Anton
Paar, Graz, Austria). Prior to analysis, the digests were diluted with
milli-Q water and subsequently the total element concentration
was determined using inductively coupled plasma mass spec-
trometry (ICP-QQQ-MS) (Agilent 8800, Agilent Technologies,
Waldbronn, Germany). Quantification was done using external
calibration with internal standardization. Analytical quality was
assessed by running selected samples in duplicate (relative stan-
dard deviation (RSD) values in the range 1e20% for all elements)
and by including the certified reference material (CRM) ERM-
CD200 Bladderwrack [18] in the analytical run.Table 1
Nutrient composition of test meals (g/serving).a





Dietary fibre (g/serving) 1.8
Water (g) 206.7
a Proximates of the test meals foods where obtained from the Dankost PRO software
Vejen, Denmark).The content of iodine in the seaweed samples was determined
following the principles in EN15111:2007 [19]. Briefly, subsamples
of seaweed (approx. 0.3 g) were extracted using 4% tetramethy-
lammonium hydroxide in an oven at 90 C for 3 h. Prior to analysis
the extracts were diluted with water and filtered and subsequently
the iodine concentration determination using inductively coupled
plasma mass spectrometry (Agilent 7500ce, Agilent Technologies,
Waldbronn, Germany). Quantification was done at m/z 127 using
external calibration with internal standardization with tellurium at
m/z 125. Analytical quality was assessed by running selected
samples (n ¼ 3) in duplicate (RSD ¼ 2.7%) and the use of the
reference material CD200 Bladderwrack, where the obtained re-
sults was in good agreement with the target value for iodine
established in a collaborative trial [20].2.6. Measurements of subjective appetite sensations
Appetite registration was measured at all three test days by
repeated visual analogue scales (VAS). VAS was used as a replace-
ment for a categorical questionnaire to register scores for satiety,
hunger, prospective food intake, fullness, comfort, and ad libitum
energy intake as continuous variables. The first appetite assess-
ment was carried out before consumption of the test meal (after
10e12 h fasting). Subjects were hereafter instructed to register VAS
every approximately 20 min, following a guideline on a tablet
screen, until the last registration at 180min postprandially after the
ad libitum meal. VAS was constructed as a digital horizontal line,
equal to a 100 mm analogue line on a paper, with the question of
interest set above the line. The extremes of the response options
were indicated as vertical marks at each end of the line. The VAS
equal to 0 and 100 mm is equivalent as follows: satiety (“I am
completely empty” and “I cannot eat another bite”), hunger (“I am
not hungry at all” and “I have never been more hungry”), pro-
spective food intake (“How much do you think you can eat?”
“Nothing at all” and “A lot”), fullness (“How full are you?” “I am
totally full” and “Not full at all”) and comfort (“How comfortable do
you feel?” “Not comfortable at all” and “Very comfortable”). The
participants were instructed to assess each question andmark with
a vertical line presented on the tablet screen. The VAS registration
was done using a digital tablet (Lenovo ThinkPad 10) running a
VAS-assessment program, Acqui (Laugesen, J. L. at XYZT, Denmark,
www.sensory.dk).2.7. Statistical analyses
Formal power calculations were not possible since this study is
the first to test the effect of seaweeds on postprandial glycaemia,
however we have based the number of participants on previous
comparable studies with coffees [21] or berries [22].
Statistical analysis was performed using RStudio software
(version 1.0.153, ©2009e2016 Rstudio, Inc.) and R (version 3.4.1, R







[43] and from analysis performed by a ISO 17025 accredited laboratory (Eurofins,
N. Zaharudin et al. / Clinical Nutrition 40 (2021) 830e838 833[23]. The descriptive data are presented as mean ± SD, ±SEM. All
variables were checked for outliers and missing data. Dependent
variables were inspected for homogeneity of variance and normal
distribution using plots of residuals and normal probability. Non-
normally distributed data were logarithmically transformed and
reassessed for normal distribution before further analysis. Glucose,
insulin, C-peptide, GLP-1 responses, and VAS scores were calcu-
lated as the incremental area under the curve (iAUC) from baseline
values. Blood concentrations of glucose, insulin, C-peptide and GLP-
1 are presented as mmol/L, pmol/L, pmol/L and pmol/L respectively.
Data for VAS questions are shown as mm within the range of
0e100 mm. R lme4 package [24] was used to perform a linear
mixed model (LMM) analysis using ANOVA for repeated measures
on all outcomes, with time, treatment, and body weight as fixed
effects and subject, sex, and visit (randomization order) added as
random effects. Tukey's post hoc test for pairwise comparisons
were performed using R multcomp [25], at each time point with
time 0 as a co-variate if the model showed statistical significance.
The same procedurewas applied to all VAS questions. All 2-sided p-
values < 0.05 were considered statistically significant.
3. Results
3.1. Participant characteristics
Forty subjects were screened and 20 healthy subjects (9 males
and 11 females) were recruited. All volunteers completed the study,
which gave a dropout rate of 0% (Fig. 1). The baseline characteristics
of the subjects are shown in Table 2.
3.2. Nutrient content and mineral elements
The nutrient and mineral contents varied between the two
species, LD and UP. In general, both of them had approximately 1.5 g
higher dietary fibre content (Table 1) compared to the control meal.
Table 3 shows an overview of the selected mineral contents of the
tested seaweeds. Furthermore LD also has 5 times higher iodine
content and almost 20 times higher K/Na ratio than UP (Table 3).
3.3. Blood glucose, insulin, C-peptide and GLP-1 response
There were no differences from control in iAUC for glucose, log-
transformed insulin or C-peptide after intake of any of the two
seaweed meals (Table 4). However, glucose, insulin and C-peptide
response was changed when including body weight in statistics by
using a 3-factor interaction model meal * time * body weight
(Table 4). In order to illustrate this effect of body weight graphically
we performed a sub-analysis by weight using the participants’
median weight, 63 kg as a cutoff. The two weight groups;  63 kg
(n ¼ males:0, females:10) and >63 kg (n ¼ males:9, females:1) did
not differ by BMI (median BMI was 21.15 kg/m2 for  63 kg group
and 21.39 for > 63 kg group) and consequently differed by height,
but showed no difference in fasting glucose or insulin at baseline.
Participants weighing  63 kg had a reduced glucose response
compared to control meals at 40, 60 and 90 min both after LD
(P ¼ 0.02, P ¼ 0.001, and P ¼ 0.004, respectively) and UP (P ¼ 0.04,
P ¼ 0.02, P ¼ 0.01, respectively) meals. Participants weighing
63 kg had a reduced glucose response after meals with LD at
120 min (P ¼ 0.04) compared to control (Fig. 2 and Supplemental
Table S1). The effect of weight was independent of sex
(Supplemental Table S2).
The insulin data was log transformed before the analysis. After
adjustment for body weight, seaweed ingestion resulted in a lower
postprandial insulin response, particularly between 20 and 60 min
(Table 4 and Supplemental Fig. S2). Females had a lower insulinresponse at 20 min (P ¼ 0.004) after UP treatment. After LD
ingestion, males had a lower insulin response at 20, 40 and 60 min
(P ¼ 0.03, P ¼ 0.003, P ¼ 0.05 respectively), compared to control
(Supplemental Table S3). iAUC for C-peptide was significantly
higher in control, only after the correction for body weight
(Table 4). C-peptide secretion was overall lower after the LD meals
(P ¼ 0.02) compared to control (Supplemental Table S4 and
Supplemental Fig. S3). The iAUC for GLP-1was higher after intake of
LD when compared to control (P ¼ 0.017). The LMM analysis,
revealed an overall increase of GLP-1 for LD compared with control
(P ¼ 0.05). Thus, the GLP-1 secretion was increased at 120 min
(P ¼ 2.2e-05) after intake of the LD meal compared to the control
meal (Fig. 3 and Supplemental Table S5).
3.4. Appetite and comfort scores
The postprandial changes in satiety, hunger, fullness, antici-
pated prospective food consumption, comfort and ad libitum en-
ergy are shown in Table 4. Satiety and fullness iAUC were higher
after intake of UP (P ¼ 0.0002 and P ¼ 0.008, respectively) and LD
(P ¼ 0.032 and P ¼ 0.001, respectively) compared to control. More
precisely the subjects felt more satiated after ingesting UP, at
20min (P¼ 0,0030) and percived an increased sensation of fullness
after intake of the UP meal at 20 min (P ¼ 0.0002) and at 50 min
(P¼ 0.01) and after the LDmeal at 20 min (P¼ 0.041 in comparison
to the control meal (Fig. 4). There were no differences in iAUC be-
tween the three test meals for scores of hunger and anticipated
prospective food consumption. However, hunger was reduced after
the UP meal at 20 min (P ¼ 0.0005) and subjects had a reduced
desire to eat after the UP test-meal at 20 min (P ¼ 0.001), 40 min
(P ¼ 0.02), 50 min (P ¼ 0.01), 70 min (P ¼ 0.04) and at 100 min
(P ¼ 0.05), compared to control (Fig. 5). The effects on the appetite
scores did not remain after 200 min and comfort scores did not
change at any time. The ad libitum energy intake at 200minwas not
different between the test meals.
4. Discussion
Our findings suggested that the brown seaweeds, LD and UP,
may reduce postprandial plasma glucose in healthy adults after a
starchy meal. However, the effect is only seen when body weight is
included in the statistical model, indicating that the effect of a fixed
dose of seaweed decreases with increased body weight. The post-
prandial serum insulin response was lower after the consumption
of seaweeds. LD resulted in a lower iAUC for C-peptide and a higher
iAUC for GLP-1.
Brown seaweeds contain potentially bioactive compounds that
inhibited a-amylase and a-glucosidase enzymes in vitro and
reduced blood glucose and plasma insulin concentrations in mice
[26,27]. Polyphenols, fucoxanthin and fatty acids found in LD and
UP inhibit a-glucosidase activities resulting in a reduced rate of
glucose liberation thereby reducing the postprandial rise in blood
glucose. Other nonpolar components including oleic acid and
linoleic acid found in LD also seem to inhibit a-glucosidase in vitro
[28]. Crude water extracts from different brown seaweeds strongly
inhibit the enzyme Dipeptidyl peptidase-4 (DPP-4) and stimulate
GLP-1 and GIP secretion in vitro [29]. Furthermore, various organic
extracts from other Sargassum species (S. polycystum and
S. wightii) exhibit similar properties in vitro [30,31]. The results
from our study provide additional evidence that relatively small
dietary intakes of whole seaweed may affect postprandial plasma
glucose, serum insulin and GLP-1 concentrations in healthy human
adults.
High contents of dietary fiber in LD and UP may lead to re-
ductions in blood glucose and insulin concentrations [10]. However
Fig. 1. Participant flow chart. * Not included in any analysis.
Table 2
Subjects characteristics at baseline.a
Subject characteristics All (n ¼ 20) Males (n ¼ 9) Females (n ¼ 11)
Age (y) 28.8 ± 5.4 30.3 ± 7.1 27.5 ± 3.4
Height (cm) 171.3 ± 14.5 183.6 ± 10.0 160.7 ± 7.7
Weight (kg) 63.6 ± 11.5 73.2 ± 9.7 55.9 ± 5.4
BMI (kg/m2) 21.4 ± 2.2 21.6 ± 1.2 21.7 ± 1.9
Waist circumference (cm) 76.4 ± 8.0 81.0 ± 6.7 71.8 ± 6.9
Blood pressure, systolic (mm Hg) 110.3 ± 0.9 112.5 ± 1.5 108.3 ± 0.4
Blood pressure, diastolic (mm Hg) 67.8 ± 0.2 63.6 ± 0.6 70.6 ± 0.6
Fasting blood glucose mmol/L 5.3 ± 0.4 5.3 ± 0.4 5.3 ± 0.5
Fasting blood insulin pmol/L 45.5 ± 26.1 39.3 ± 17.3 50.6 ± 30.9
Fasting blood GLP-1 pmol/L 17.9 ± 7.0 17.5 ± 4.9 18.3 ± 8.3
HOMA-IR 1.78 ± 1.0 1.56 ± 0.7 1.97 ± 1.1
a Numbers represent mean ± SD.
Table 3
Content of selected minerals in soaked, blotted Laminaria digitata and Undaria
pinnatifida.
Mineral composition Laminaria digitata Undaria pinnatifida
Arsenic (As) (mg/100g) 4.00 5.81
Cadmium (Cd) (mg/100g) 0.018 0.137
Chromium (Cr) (mg/100g) 0.048 0.096
Iodine (I) (mg/100g) 164.6 32.0
Zinc (Zn) (mg/100g) 5.53 4.00
Calcium (Ca) (g/100g) 2.01 1.27
Magnesium (Mg) (g/100g) 0.683 0.406
Potassium (K) (g/100g) 1.46 0.275
Sodium (Na) (g/100g) 2.77 5.46
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the 1.8 g provided in our study [32]. Brown seaweeds contain be-
tween 19.6 and 64.9% of soluble fiber depending on the species [33]
and the fiber content of around 40% observed for our batches is
therefore not extraordinary. The soluble fiber from seaweed dis-
solves in water to form a viscous gel [33], which might lead to a
reduced rate of gastric emptying [33] or simply a reduced substrate
diffusion resulting in a lower intestinal glucose absorption rate.
Alternatively, glucose liberation from degradable polysaccharides
such as starch may be delayed after entering into the duodenum
thereby retarding the rate of glucose reaching the intestinal con-
tents when seaweeds are consumed together with a meal rich in
starch.
Table 4
Result for all measured endpoints after ingestion of the three test meals.
Outcome Control
Total iAUC (n ¼ 20)
Laminaria digitata
Total iAUC (n ¼ 20)
Undaria pinnatifida
Total iAUC (n ¼ 20)
P - value iAUC P - value LMMrm
Biochemistry
Glucose (mmol/L) 135.9 ± 76.8 105.4 ± 45.4 104.7 ± 80.1 0.24 0.003**
Insulin (pmol/L) 11606 ± 8989 9552 ± 6954 10095 ± 7377 0.28 0.04*
C-peptide (pmol/L) 77579 ± 48812 65921 ± 37820 67430 ± 41563 0.08 0.04*
GLPx1-1 (pmol/L) 196.2 ± 239.9 370.2 ± 261.9 250.6 ± 243.8 0.02* 0.05*
Appetite scores
Satiety (mm) 642 ± 886 1315 ± 1399 1919 ± 1810 0.004 ** 0.009**
Hunger (mm) 2138 ± 1837 1098 ± 1192 1509 ± 2351 0.18 0.02*
Fullness (mm) 806 ± 705 1405 ± 1323 2074 ± 1746 0.008 ** 0.02*
Prospective food-consumption (mm) 1675 ± 1236 1204 ± 1631 1161 ± 1488 0.32 0.03*
Comfort (mm) 1191 ± 1613 916 ± 1155 1179 ± 1586 0.55 0.81
Ad libituma (g) 629 ± 312 545 ± 251 627 ± 277 NA 0.13a
Comparison of iAUC, incremental AUC for all outcomes and LMMRM linear mixed model repeated measures with outcome ~ meal *time*weight þ visit, as the dependent
variable. The fixed effect “meal” is presented as mean ± SD. P - values are obtained by gradually reducing the full model to a model showing a difference relevant to the
outcome. In case of no difference, the p-value for the full model is displayed. The significant codes are: *** for 0.001; ** for 0.01 and * for 0.05. NA; not applicable; the ad libitum
food intakes could be compared using a linear mixed-effect model only.
a Presented as mean gram of the eaten meal.
Fig. 2. Effects of Laminaria digitata and Undaria pinnatifida on postprandial plasma glucose concentrations (mmol/L) in subjects weighing < 63 kg (A) and subjects
weighing  63 kg (B) at 0, 20, 40, 60, 90, 120 and 180 min after the intake of control and seaweed meals. C ¼ control meal, L ¼ Laminaria digitata and U ¼ Undaria pinnatifida. Values
are represented as means ± SEM, (n ¼ 10). Significant symbols: ‘*’ ¼ Laminaria digitata, ‘#’ ¼ Undaria pinnatifida.
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intake of LD and UP observed in our study is probably a dose
dependent effect. By adding body weight as a fixed effect in the
LMM model, it appears that weight had an influence on the post-
prandial glucose response after the test meals. The subjects
weighing <63 kg had a significantly lower glucose response after
both LD and UP especially pronounced between 40 - 90 min
(Supplemental Table 1). This could be explained to some extent by
the weight span between the enrolled subjects (48.5e93 kg), sug-
gesting that there may be a dose-dependent effect of LD and UP.
The average fasting concentration of GLP-1 were lower than the
postprandial GLP-1 concentrations at time 20 min after all testmeals with LD, UP, or control. The increment correlated with
commonly observed peak-response approximately 30 min post-
prandially [34,35]. However, as no data is available from baseline to
20 min and at 60 min, it cannot be ruled out that the Cmax of GLP-1
was higher or occurred before or after time 20 min. GLP-1 con-
centrationswere significantly different at 120min after intake of LD
compared to control. We speculate that the time course for lami-
narin to inhibit DPP-4 is delayed because of the viscous dietary fibre
load from LD causing a delayed absorption of the meal and as a
result, an increase in GLP-1 at time 120 min.
LD and UP also increased the sensation of satiety and reduced
any feelings of hunger. As opposed to the lack of effects of pea
Fig. 3. Effects of Laminaria digitata and Undaria pinnatifida on postprandial plasma
GLP-1 concentrations picomoles per litre (pmol/L) at 0, 20, 60 and 120 min after the
intake of control and seaweed meals. C ¼ control meal, L ¼ Laminaria digitata and U ¼
Undaria pinnatifida. Values are represented as means ± SEM (n ¼ 18). Significant
symbols: * Laminaria digitate.
Fig. 4. Effects of Laminaria digitata and Undaria pinnatifida on postprandial perception of satiety (A) and hunger (B) at 0, 20, 40, 60, 70, 100, 130 and 180 min after the intake of
control and seaweed meals. C ¼ control meal, L ¼ Laminaria digitata and U ¼ Undaria pinnatifida. Values are represented as means ± SEM (n ¼ 20). Significance symbols: * Laminaria
digitata, #Undaria pinnatifida.
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that consumption of brown seaweed affected subjective satiety and
hunger. From the corresponding VAS questions, it appears that
intake of just 5 g of whole, dried LD and UP affect several appetite
related feelings for more than 1 h postprandially and satiety for
more than two hours. This implies that these seaweed species are
potential candidates to reduce energy intake for several hours after
intake of dried LD and UP. The effect is possibly due to their content
of the polysaccharide, alginate, and perhaps other soluble dietary
fibers having a satiating effect that may be caused by bulking or to
reduced gastric emptying rate [37]. Previously, alginate from brownseaweed is linked to increased satiety by delaying gastric clearance,
stimulating gastric stretch receptors, and attenuating nutrient ab-
sorption [11].
The analysis of nutrient and mineral composition show that LD
and UP contained some protein but only small amounts of fat.
Both brown seaweeds, and especially LD, were rich in minerals
such as potassium (K), calcium (Ca) and magnesium (Mg), which
are proposed to improve glycaemic control [38]. Both LD and UP
also contained zinc (Zn) and chromium (Cr) in relatively high
amounts, which are associated with improved circulating glucose
levels [39,40]. LD and UP contained high amounts of iodine so
caution may be needed in case of frequent consumption as 0.36 g
LD and 1.9 g UP would exceed the recommended upper tolerable
level of daily intake at 600 mg/day for adults [41]. Despite the high
iodine content in the test meals, the acute exposure are consid-
ered safe for subjects who are not hypersensitive to iodine since
single acute doses from foods are not known to give adverse ef-
fects [42].
The study has several strengths. The food intake is fully
controlled and the cross-over design assures individual control of
effects. Also, the follow-up periods are fully monitored and super-
vised providing good assurance for validity of the measurements.
Our study is novel, being the first to study the effects of common
edible brown seaweeds in humans. The species were selected based
on their ability to inhibit the starch degrading enzymes, alpha-
amylase and alpha-glucosidase in vitro [12,13]. This provides arationale for their effects on blood glucose as well as identification
of the components potentially providing the bioactivity.
The study also has some weaknesses. The control meal con-
tained only a limited amount of pea fiber. Pea protein (10 g) com-
bined with pea hull fiber (7 g) is well known to have effects on
postprandial blood glucose and this effect was not reduced by
adding insoluble hull fiber [36]. Therefore, our use of 5 g pea pro-
tein as control represents a low dose of another bioactive anti-
glycaemic meal component and may therefore have partially
masked an effect of the seaweeds in this study. We attempted to
blind the subjects, yet it was not possible to eliminate the taste
Fig. 5. Effects of Laminaria digitata and Undaria pinnatifida on postprandial feellings of hunger (A) and anticipated prospective food consumption (B) at 0, 20, 40, 60, 70, 100, 130 and
180 min after the intake of control and seaweed meals. C ¼ control meal, L ¼ Laminaria digitata and U ¼ Undaria pinnatifida. Values are represented as means ± SEM (n ¼ 20).
Significance symbols: * Laminaria digitata, #Undaria pinnatifida.
N. Zaharudin et al. / Clinical Nutrition 40 (2021) 830e838 837differences of the control and seaweed meals. Thereby, VAS scores
might be affected from the participants’ awareness of the tested
meal. Since this is only a meal study it provides no information on
longer-term effects of seaweed. Finally, clinical significance of a
single dietary exposure is limited for achieving the glycaemic
control.
Further studies on isolated bioactive compounds from seaweed
and a longer-term study with different groups of volunteers such as
healthy -or hyperinsulinemic subjects are needed in order to see
the individual contributions of seaweed components to the sati-
ating effects and to glucose/insulin maintenance over time. In
addition, further work is needed to identify the bioactive com-
pounds, longer-term effects, mixed-meal effects, and mineral
bioavailability in humans after LD and UP intake.5. Conclusions
This study provides human trial evidence for an effect of brown
seaweeds on glycemic and insulinemic responses, GLP-1 secretion,
and appetite. Brown seaweed lowers the postprandial glucose and
insulin response as well as hunger in humans exposed to a highly
degradable linear starch and increased the postprandial feeling of
satiety and fullness in healthy subjects of both sexes. Consumption
of brown seaweed may be recommended as part of the diet for
people with hyperglycaemic disorders, provided issues with po-
tential excessive iodine intake can be avoided.Sources of support
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